The International development of PROQOL-HCV: An instrument to assess the health-related quality of life of patients treated for Hepatitis C virus - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue BMC Infectious Diseases Année : 2016

The International development of PROQOL-HCV: An instrument to assess the health-related quality of life of patients treated for Hepatitis C virus

Andrew Richard Armstrong
  • Fonction : Auteur
Susan Elizabeth Herrmann
  • Fonction : Auteur
Olivier Chassany
  • Fonction : Auteur
Christophe Lalanne
Mariliza Henrique da Silva
  • Fonction : Auteur
Eliana Galano
  • Fonction : Auteur
Patrizia M. Carrieri
  • Fonction : Auteur
Philippe Sogni
  • Fonction : Auteur
Martin Duracinsky
  • Fonction : Auteur

Résumé

Background : Hepatitis C virus (HCV) compromises Health-related Quality of Life (HRQL) with detriments to Physical, Mental and Social health domains. Treatment with interferon and ribavirin is associated with side effects which further impair HRQL. New treatments appear potent, effective and tolerable. However, Patient Reported Outcomes instruments that capture the impact on HRQL for people with hepatitis C are largely non-specific and will be needed in the new treatment era. Therefore, we developed a conceptually valid multidimensional model of HCV-specific quality of life and pilot survey instrument, the Patient Reported Outcome Quality of Life survey for HCV (PROQOL-HCV). Methods : HCV patients from France (n = 30), Brazil (n = 20) and Australia (n = 20) were interviewed to investigate HCV-HRQL issues raised in the scientific literature and by treatment specialists. Interviews were recorded, transcribed and translated into English and French. Results : Fifteen content dimensions were derived from the qualitative analysis, refined and fitted to four domains: (1) Physical Health included: fatigue, pain, sleep, sexual impairment and physical activity; (2) Mental Health: psychological distress, psychosocial impact, and cognition; (3) Social Health: support, stigma, social activity, substance use; (4) Treatment: management, side effects, and fear of treatment failure. The impact of some dimensions extended beyond their primary domain including: physical activity, cognition, sleep, sexual impairment, and the three treatment dimensions. A bank of 300 items was constructed to reflect patient reports and, following expert review, reduced to a 72-item pilot questionnaire. Conclusion : We present a conceptually valid multidimensional model of HCV-specific quality of life and the pilot survey instrument, PROQOL-HCV. The model is widely inclusive of the experience of hepatitis C and the first to include the treatment dimension.
Fichier principal
Vignette du fichier
12879_2016_Article_1771.pdf (1.18 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03067770 , version 1 (26-05-2021)

Licence

Paternité - Pas d'utilisation commerciale - Pas de modification

Identifiants

Citer

Andrew Richard Armstrong, Susan Elizabeth Herrmann, Olivier Chassany, Christophe Lalanne, Mariliza Henrique da Silva, et al.. The International development of PROQOL-HCV: An instrument to assess the health-related quality of life of patients treated for Hepatitis C virus. BMC Infectious Diseases, 2016, 16, 11 p. ⟨10.1186/s12879-016-1771-0⟩. ⟨hal-03067770⟩
51 Consultations
62 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More